Australia's most trusted
source of pharma news
Tuesday, 21 July 2026
Posted 20 July 2026 AM
Twelve drugs have joined the PBS listing wait queue after reaching the last stage before listing occurs, bringing the total number of contenders for an August PBS listing to 17.
Recently joining the wait list is Apellis’ Syfovre, which is a step off becoming the first treatment for geographic atrophy to be listed on the PBS after reaching the government processes stage in June, also known as the last stage before listing occurs.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.